NORGINE DANMARK A/S: Financial statements 2013
CVR: 29310025
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
NORGINE DANMARK A/S (CVR 29310025) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 15,185,089 and a net result of DKK 1,723,365 compared with DKK 1,546,607 the year before. That is an increase of 15.4% compared with the year before. Equity in the 2013 report amounted to DKK 13,270,275. The solvency ratio was 27.9%.
- Gross Profit
- DKK 15,185,089
- Profit/Loss
- DKK 1,723,365
- Equity
- DKK 13,270,275
- Total Assets
- DKK 47,524,676
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 15.2 mio. | 1.7 mio. | 13.3 mio. | - |
| 2012 | - | 13.2 mio. | 1.5 mio. | 11.5 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
NORGINE DANMARK A/S has published its annual report for 2012. Gross profit came to DKK 13,159,736, and the net result was DKK 1,546,607.
As of March 18, 2013, Peter Legarth Petersen has joined the board of directors of NORGINE DANMARK A/S.
As of March 18, 2013, David Robert Todd has left the board of directors of NORGINE DANMARK A/S.
About NORGINE DANMARK A/S
NORGINE DANMARK A/S is a Danish company of the type Aktieselskab based in Valby, founded in 2006. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Erik Niklas Eriksson. The board consists of Ina Høydal Helle (chair), Erik Niklas Eriksson and Laura Elizabeth Barrell. The company is owned by Norgine B.V.. The company has 17 employees (2018). In 2025, the company reported a gross profit of DKK 26,083,000 and a net result of DKK 4,691,000 compared with DKK 10,357,000 the year before. Equity in the 2025 report amounted to DKK 88,954,000.